HSO 0.00% $2.46 healthscope limited.

May 22 (Reuters) - Healthscope Ltd (HSO) : COMPLETED PREVIOUSLY...

  1. 184,640 Posts.
    lightbulb Created with Sketch. 2711

    May 22 (Reuters) - Healthscope Ltd (HSO) :

    • COMPLETED PREVIOUSLY ANNOUNCED REVIEW OF ITS PORTFOLIO OF 45 HOSPITALS
    • FY18 RESULTS WILL INCLUDE A NON-OPERATING CHARGE OF APPROXIMATELY $17 MILLION COMPRISING ASSET WRITE-DOWNS, REDUNDANCIES AND OTHER COSTS
    • GEELONG PRIVATE, COTHAM PRIVATE AND FRANKSTON PRIVATE HOSPITALS EXPECTED TO INCUR HOSPITAL OPERATING EBITDA LOSS IN FY18 OF ABOUT $8 MILLION
    • HOSPITALS OPERATING EBITDA IN SECOND HALF IS EXPECTED TO BE IN LINE WITH PRIOR CORRESPONDING PERIOD
    • FY18 RESULTS WILL ALSO INCLUDE A NON-OPERATING IMPAIRMENT CHARGE OF APPROXIMATELY $68 MILLION
    • HEALTHSCOPE IS TARGETING FY19 HOSPITAL OPERATING EBITDA GROWTH OF AT LEAST 10% COMPARED WITH FY18
    • EXPECTS HOSPITAL OPERATING EBITDA FOR FY18 TO BE BETWEEN $340 MILLION AND $345 MILLION
    • TO CLOSE GEELONG PRIVATE HOSPITAL AND COTHAM PRIVATE HOSPITAL, AND RECORD IMPAIRMENT RELATING TO FRANKSTON PRIVATE HOSPITAL
    • RECEIVED NUMBER OF APPROACHES TO BUY ASIAN PATHOLOGY BUSINESS
    • INITIATED A SALE PROCESS TO ASSESS VALUE THAT COULD BE GENERATED BY A DIVESTMENT OF ASIAN PATHOLOGY
 
watchlist Created with Sketch. Add HSO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.